EMAIL THIS PAGE TO A FRIEND

Cold Spring Harbor perspectives in medicine

Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease.


PMID 22393531

Abstract

In this work we consider marketed drugs for Alzheimer disease (AD) including acetylcholinesterase inhibitors (AChE-Is) and antiglutamatergic treatment involving the N-methyl-d-aspartate (NMDA) receptor. We discuss medications and substances available for use as cognitive enhancers that are not approved for AD or cognitive impairment, and other neurotransmitter-related therapies in development or currently being researched. We also review putative therapies that aim to slow disease progression by mechanisms not directly related to amyloid or tau.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

H5902
(−)-Huperzine A
C15H18N2O